Nucleated red blood cell counts and erythropoietin levels in high-risk neonates.
BACKGROUND
The presence of increased numbers of nucleated red blood cells (NRBC) and increased levels of erythropoietin (EPO) in the circulation of neonates has been associated with states of relative hypoxia. The aim of this study is to assess the pattern of NRBC counts and EPO levels in a group of high-risk neonates under stress conditions and determine the short-term outcome for these babies by using these parameters.


METHODS
There were 69 high-risk neonates; 14 intrauterine growth retarded (IUGR), 25 preterm infants, 18 term infants with asphyxia and 12 infants of diabetic mothers. Control groups included healthy, term infants delivered either vaginally (n = 18) or with cesarean section (n = 19). Three blood samples were obtained from each infant within 12 h (initial), 3 days and 7 days after birth to measure NRBC counts and EPO levels. Neonatal and short-term outcomes at 3 and 6 months of age were determined.


RESULTS
There was no significant difference among the groups with regard to the initial serum EPO concentrations. The initial NRBC counts were significantly lower in the control groups compared with the study groups (P = 0.002). While there was no significant difference between patients with good and poor outcome in terms of EPO concentrations of initial samples, a significant difference existed in terms of NRBC counts (P = 0.038).


CONCLUSIONS
Both serum EPO level and NRBC count provide limited clinical benefit in the detection of pathological conditions of the neonatal period, but NRBC count determination seems to be especially helpful in predicting short-term neurodevelopmental outcome.
Vatansever
Ulfet
U
Department of Pediatrics, Faculty of Medicine, Trakya University, Edirne, Turkey. u_vatansever@hotmail.com
Acunaş
Betül
B
Demir
Muzaffer
M
Karasalihoglu
Serap
S
Ekuklu
Galip
G
Ener
Seralp
S
Pala
Ozer
O
D000704:Analysis of Variance; D004900:Erythroblasts; D004906:Erythrocyte Count / Q000379:methods; D004921:Erythropoietin / Q000032:analysis*; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000097:blood*; D007230:Infant, Low Birth Weight / Q000097:blood*; D007231:Infant, Newborn; D007234:Infant, Premature / Q000097:blood*; D008297:Male; D011446:Prospective Studies
D004921:Erythropoietin